Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer
NCT00010244 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 306
Last updated 2021-02-21
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which regimen of radiation therapy is more effective for prostate cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of radiation therapy in treating patients who have localized prostate cancer.
Conditions
Interventions
- RADIATION
-
radiation therapy
Sponsors & Collaborators
-
UNICANCER
lead OTHER
Principal Investigators
-
V. Beckendorf, MD · Centre Alexis Vautrin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 0 Years
- Max Age
- 74 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-09-30
- Primary Completion
- 2007-02-20
- Completion
- 2018-03-31
Countries
- France
Study Locations
More Related Trials
-
Medical and Economic Evaluation for Intermediate-risk Prostate Cancer
NCT02271659 ·Status: UNKNOWN ·Phase: NA
-
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00714753 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)
NCT00967863 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00258466 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma
NCT04909294 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT03541850 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer
NCT02279693 ·Status: TERMINATED ·Phase: NA
-
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07325721 ·Status: RECRUITING ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery
NCT01272050 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Prostate Cancer
NCT01434290 ·Status: COMPLETED ·Phase: PHASE2
-
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer
NCT00243321 ·Status: COMPLETED ·Phase: NA
-
Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer
NCT02876237 ·Status: COMPLETED ·Phase: NA
-
Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma
NCT02264379 ·Status: COMPLETED
-
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
NCT02280356 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Hypofractionated Radiotherapy for Prostate Cancer
NCT00214097 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
NCT01859689 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer
NCT02974231 ·Status: COMPLETED
-
Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer
NCT00394511 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00002602 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer
NCT01737151 ·Status: TERMINATED ·Phase: NA
-
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
NCT04612907 ·Status: RECRUITING ·Phase: NA
-
Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men
NCT02033447 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
NCT05344235 ·Status: RECRUITING
-
Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
NCT02830165 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer
NCT07152067 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2